These observations demonstrate that 17-AAG, an Hsp90 inhibitor, can inhibit RAF inhibitor enhanced MAP Kinase signaling through destabilizing CRAF resulting in BRAFWT melanoma cell arrest and apoptosis. This evidence concerns the gene HSP90AB1 and melanoma.